Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers-Reference-Cited by-同舟云学术

Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers

Published:2019-03-12 Issue:6 Volume:13 Page:1161-1168
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Joubert Michael¹,Benhamou Pierre-Yves²,Schaepelynck Pauline³^ORCID,Hanaire Hélène⁴,Catargi Bogdan⁵,Farret Anne⁶,Fontaine Pierre⁷,Guerci Bruno⁸,Reznik Yves¹,Jeandidier Nathalie⁹,Penfornis Alfred¹⁰,Borot Sophie¹¹,Chaillous Lucy¹²,Franc Sylvia¹³,Serusclat Pierre¹⁴,Kherbachi Yacine¹⁵,Bavière Eric¹⁶,Detournay Bruno¹⁷,Simon Pierre¹⁸,Charpentier Guillaume¹³

Affiliation:

1. Diabetes Care Unit, Caen University Hospital, Caen, France

2. Department of Diabetology, Pôle DigiDune, University Hospital, Grenoble, France

3. Department of Nutrition-Endocrinology-Metabolic Disorders, Marseille University Hospital, Sainte Marguerite Hospital, Marseille, France

4. Department of Diabetology, Metabolic Diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France

5. Department of Endocrinology and Diabetes, University Hospital, Bordeaux, France

6. Department of Endocrinology, Diabetes and Nutrition, University Hospital, Montpellier, France

7. Department of Diabetology, University Hospital, Lille, France

8. Endocrinology-Diabetes Care Unit, University of Lorraine, Vandoeuvre Lès Nancy, France

9. Department of Endocrinology, Diabetes and Nutrition. CHU of Strasbourg, Strasbourg, France

10. University Paris-Sud, Orsay, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France

11. Centre Hospitalier Universitaire Jean Minjoz, Service d’Endocrinologie-Métabolisme et Diabétologie-Nutrition, Besançon, France

12. Department of Endocrinology, Diabetology and Nutrition, Institut du Thorax, Nantes University Hospital, France

13. CERITD (Centre d’étude et de Recherche pour l’Intensification du Traitement du Diabète), Evry, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France

14. Endocrinology, Diabetology and Nutrition, Clinique Portes du Sud, Venissieux, France

15. Sanofi-Diabetes, Gentilly, France

16. Voluntis, Suresnes, France

17. CEMKA-EVAL, Bourg-la-Reine, France

18. National Association of Telemedicine, Paris, France

Abstract

Benefits of telemedicine have been proven in the field of diabetes. Among a number of technical solutions, Diabeo® has been studied in both type 1 and type 2 diabetes with intensive insulin therapy. This digital therapeutic system contains a self-monitoring glucose logbook and offers automated insulin dose recommendations thanks to a fully customizable algorithm. In addition, the cloud-based dedicated software also has features to facilitate remote monitoring, including a platform for diabetes nurses who perform coaching and treatment adjustment. A detailed description of this telemedicine system is provided, as well as results of completed clinical studies. In particular, TeleDiab 1’s positive results on HbA1c in type 1 diabetes are detailed. We conclude with a discussion of the role of this telemedicine system within the landscape of mobile apps for diabetes.

Funder

sanofi

Voluntis

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1932296819834054

Reference15 articles.

1. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets

2. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry